Intervacc applies for a Permit for Sale and Distribution of Strangvac in the U.S.
Stockholm, February 16, 2022 - Intervacc AB (publ) announces that the Company’s application for a Permit for Sale and Distribution of Strangvac in the U.S. has been submitted to the U.S. Department of Agriculture (USDA).
Intervacc is seeking approval for Strangvac, a vaccine against the highly contagious equine disease strangles that affects horses worldwide. Strangvac has been approved for use in the European Union, the United Kingdom, Norway, and Iceland since the autumn of 2021.
“The number of horses in the United States is estimated to be around 10 million representing the largest